149 related articles for article (PubMed ID: 38726878)
21. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
[TBL] [Abstract][Full Text] [Related]
22. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
[TBL] [Abstract][Full Text] [Related]
23. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
24. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
Murina F; Vicariotto F; Di Francesco S
New Microbiol; 2018 Jul; 41(3):220-224. PubMed ID: 29874389
[TBL] [Abstract][Full Text] [Related]
25. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
Lee CY; Cheu RK; Lemke MM; Gustin AT; France MT; Hampel B; Thurman AR; Doncel GF; Ravel J; Klatt NR; Arnold KB
Nat Commun; 2020 Dec; 11(1):6147. PubMed ID: 33262350
[TBL] [Abstract][Full Text] [Related]
26. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
27. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
[TBL] [Abstract][Full Text] [Related]
28. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
[TBL] [Abstract][Full Text] [Related]
29. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
Chavoustie SE; Carter BA; Waldbaum AS; Donders GGG; Peters KH; Schwebke JR; Paull JRA; Price CF; Castellarnau A; McCloud P; Kinghorn GR
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():13-18. PubMed ID: 31812702
[TBL] [Abstract][Full Text] [Related]
30. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
Russo R; Karadja E; De Seta F
Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
[TBL] [Abstract][Full Text] [Related]
32. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.
Srinivasan S; Liu C; Mitchell CM; Fiedler TL; Thomas KK; Agnew KJ; Marrazzo JM; Fredricks DN
PLoS One; 2010 Apr; 5(4):e10197. PubMed ID: 20419168
[TBL] [Abstract][Full Text] [Related]
33. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Cohen CR; Wierzbicki MR; French AL; Morris S; Newmann S; Reno H; Green L; Miller S; Powell J; Parks T; Hemmerling A
N Engl J Med; 2020 May; 382(20):1906-1915. PubMed ID: 32402161
[TBL] [Abstract][Full Text] [Related]
34. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis.
Petricevic L; Witt A
BJOG; 2008 Oct; 115(11):1369-74. PubMed ID: 18823487
[TBL] [Abstract][Full Text] [Related]
35. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
[TBL] [Abstract][Full Text] [Related]
36. Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.
Xiao B; Wu C; Song W; Niu X; Qin N; Liu Z; Xu Q
Front Cell Infect Microbiol; 2019; 9():189. PubMed ID: 31245300
[TBL] [Abstract][Full Text] [Related]
37. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Lactobacillus and Gardnerella vaginalis from women with or without bacterial vaginosis and their relationships in gnotobiotic mice.
Teixeira GS; Carvalho FP; Arantes RME; Nunes AC; Moreira JLS; Mendonça M; Almeida RB; Farias LM; Carvalho MAR; Nicoli JR
J Med Microbiol; 2012 Aug; 61(Pt 8):1074-1081. PubMed ID: 22539000
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.
Lambert JA; John S; Sobel JD; Akins RA
PLoS One; 2013; 8(12):e82599. PubMed ID: 24376552
[TBL] [Abstract][Full Text] [Related]
40. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study.
Donders GG; Van Bulck B; Van de Walle P; Kaiser RR; Pohlig G; Gonser S; Graf F
Gynecol Obstet Invest; 2010; 70(4):264-72. PubMed ID: 21051846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
